US 12233135
Therapeutic constructs for treating cancer
granted A61KA61K2039/505A61K2239/31
Quick answer
US patent 12233135 (Therapeutic constructs for treating cancer) held by PRECISION MOLECULAR INC. expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PRECISION MOLECULAR INC.
- Grant date
- Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K2239/31, A61K2239/38, A61K2239/55